ISRCTN16584442已完成未知
COgnitive Rehabilitation for Parkinson's Disease Dementia: a pilot trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
2016 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/27000036 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/27446628 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29314218 [added 15/03/2019]
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 22/06/2015:
- •1. Diagnosis of Parkinson's disease (PD) according to the UK PD Brain Bank Diagnostic Criteria and a diagnosis of PD dementia according to the Movement Disorder Society consensus criteria or
- •2. Diagnosis of Dementia with Lewy Bodies (DLB) according to the DLB Consortium consensus criteria.
- •3. Clinical diagnosis of mild to moderate dementia with an ACE-III score of =82
- •4. Participants will preferably have a carer or family member who is willing to participate but this is not an absolute requirement
- •5. Participants should be on stable medication for their Parkinsonism and cognition (including acetylcholinesterase inhibitors) for four weeks prior to commencement with no changes planned for the duration of the intervention. Any unplanned changes in medication during the intervention will be documented
- •Previous inclusion criteria:
- •1. Diagnosis of Parkinson's disease (PD) according to the UK PD Brain Bank Diagnostic Criteria and a diagnosis of PD dementia according to the Movement Disorder Society consensus criteria or;
- •2. Diagnosis of Dementia with Lewy Bodies (DLB) according to the DLB Consortium consensus criteria.
- •3. Clinical diagnosis of mild to moderate dementia with an ACE-III score of <80
- •4. Participants will preferably have a carer or family member who is willing to participate but this is not an absolute requirement
- •5. Participants should be on stable medication for their Parkinsonism and cognition (including acetylcholinesterase inhibitors) for four weeks prior to commencement with no changes planned for the duration of the intervention. Any unplanned changes in medication during the intervention will be documented
排除标准
- •1. Lack of stability of Parkinson's disease (PD) medications, cognitive enhancers or psychotropic medication or substantial additions to medication in the four weeks before the trial or planned changes during the period of the trial
- •2. Other major psychiatric disorder not related to PD
- •3. Major depression
- •4. Other significant neurological disease
研究者
相似试验
已完成
不适用
Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients With Parkinson's DiseaseParkinson DiseaseNCT04730466Universidad Francisco de Vitoria46
已完成
2 期
Improving cognitive functioning in Parkinson*s disease with transcranial Direct Current Stimulation (PD-tDCS)cognitieve stoornissenParkinson's Disease-related mild cognitive impairment (PD-MCI)10028037NL-OMON42486Vrije Universiteit Medisch Centrum120
招募中
不适用
Pacific Northwest Udall Center (PANUC) Clinical CoreCognitive ImpairmentParkinson DiseaseNCT01720810University of Washington2,000
招募中
不适用
Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation LoopsParkinson DiseaseNCT06608875University of Zurich40
已完成
不适用
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot StudyParkinson's DiseaseNCT01469741Washington University School of Medicine74